Showing results (71-80 of 115) with videos related to

Sort By:
Pageof 12
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Randomised phase II study of methotrexate (MTX) versus methotrexate plus lonidamine (MTX + LND) in recurrent and/or metastatic carcinoma of the head and neckE Colella, M Merlano, F Blengio, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
Therapeutic equivalence of single oral doses of dolasetron mesilate and multiple doses of ondansetron for the prevention of emesis after moderately emetogenic chemotherapy. European Dolasetron Comparative Study GroupA A Fauser, B Duclos, A Chemaissani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 18, 2011
Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysisE Bria, M Milella, F Cuppone, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 24, 2001
Brachial plexus neuropathy as unusual onset of diffuse neurolymphomatosisA Pietrangeli, M Milella, S De Marco, et al.
Growth Hormone & IGF Research : Official Journal of the Growth Hormone Research Society and the International IGF Research Society|August 31, 2014
Circulating asymmetric dimethylarginine and lipid profile in pre-pubertal children with growth hormone deficiency: effect of 12-month growth hormone replacement therapyS De Marco, M L Marcovecchio, D Caniglia, et al.
British Journal of Cancer|November 27, 1999
Ifosfamide, cisplatin and etoposide combination in locally advanced inoperable non-small-cell lung cancer: a phase II studyA F Scinto, V Ferraresi, M Milella, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2010
Clinical outcome of patients with brain metastases from HER2-positive breast cancer treated with lapatinib and capecitabineG Metro, J Foglietta, M Russillo, et al.
European Journal of Cancer (Oxford, England : 1990)|July 16, 2011
Management and treatment of triple-negative breast cancer patients from the NEMESI study: an Italian experienceV Adamo, G R R Ricciardi, S De Placido, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 1998
A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancerE Van Cutsem, C Pozzo, H Starkhammar, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 1992
A phase II trial of 10-ethyl-10-deaza-aminopterin, a novel antifolate, in patients with advanced and/or recurrent squamous cell carcinoma of the head and neck. The EORTC Head and Neck Cancer Cooperative GroupJ H Schornagel, J Verweij, P H de Mulder, et al.
Pageof 12